UBiome

UBiome

Biotechnology microbial genomics company based in San Francisco

uBiome was founded in October 2012 by Jessica Richman and Zachary Apte, two scientists from the California Institute for Quantitative Biosciences. It is a privately held, citizen science startup that sequences the human microbiome.

The company's commercial products include:

  • SmartGut - a sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn's Disease, and ulcerative colitis. The test detect both beneficial and pathogenic microorganisms associated with these gut conditions.

  • SmartJane - a sequencing based women's health screening test, which genotypes all 19 clinically relevant strains of HPV, identified four common STDs (chlamydia, gonorrhea, syphilis, and mycoplasma genitalium), and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions. However, it does not screen for cancer and is not intended to replace traditional Pap smears or well woman visits.

  • SmartFlu - an upper respiratory test that analyzes nasal microbiome when a person experiences cold or flu symptoms. It detects bacteria and viruses associated with health conditions such as, the flu, common cold, and bacterial infections. This product is available by invite-only as of February 2019.

  • Explorer - a health and wellness product to understand the role that food and lifestyle can play in wellness.

In September 2018, uBiome announced that it will be supporting drug-discovery efforts using its technology at a new Cambridge, Massachusetts headquarters. It also raised $83 million in a Series C round of funding.

Timeline

April 26, 2019

uBiome offices raided by FBI

Investigation due to billing practices.

September 2018

UBiome raises a $83,000,000 series C round from Dentsu Ventures, Y Combinator, 8VC and OS Fund.

October 29, 2013

UBiome raises a $1,500,000 seed round from 500 Startups.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Adam Schwartz

Investor

Adam Spector

Investor

Ahmed Dailami

Investor

Alexandra Carmichael

Employee

Andrew Crichton

Investor

Andy Warner

Investor

AngelList Syndicates Fund Manager

Investor

Ari Meisel

Advisor

Bill Tai

Investor

Brad Porteus

Investor

Brett Jackson

Investor

Brian Cain

Investor

Brian Dexheimer

Investor

Bryan Johnson

Investor

Bryant Detwiller

Investor

Carlos Betancourt Carrero

Employee

Charles Bergmeier

Employee

Cok Mudde

Investor

Colby Holliday

Employee

Cristobal Cuart

Investor

Daniel Almonacid

Employee

Daniel Curran

Investor

Daniel Dulitz

Investor

Daniel Kellmereit

Investor

Daniel Pepper

Advisor

Page 1 of 5

Further reading

Title
Author
Link
Type
Date

uBiome is jumping into therapeutics with a healthy $83 million in Series C financing

Web

uBiome: What we know about microbiome startup, FBI raid, bankruptcy

Erin Brodwin, Lydia Ramsey and Emma Court

Web

September 5, 2019

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.